Key Events This Week
18 May: Stock opens at Rs.29.55, down 1.57% amid broader market weakness
19 May: Sharp rebound with 4.97% gain to Rs.31.02 on rising volumes
20 May: Continued momentum with 5.00% rise to Rs.32.57 ahead of upgrade
21 May: MarketsMOJO upgrades stock to Buy; closes at Rs.34.19 (+4.97%)
22 May: Slight profit-taking at Rs.33.54 (-1.90%) as Sensex gains 0.21%

Sudarshan Pharma Industries Ltd Upgraded to Buy on Strong Technical and Financial Performance
2026-05-21 08:27:27Sudarshan Pharma Industries Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The micro-cap specialty chemicals company has demonstrated robust quarterly results, sustained long-term growth, and a bullish technical outlook, prompting this positive reassessment on 20 May 2026.
Read full news article
Sudarshan Pharma Industries Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals
2026-05-21 08:04:28Sudarshan Pharma Industries Ltd has demonstrated a marked shift in price momentum, supported by a suite of bullish technical indicators. The micro-cap specialty chemicals company’s shares surged 5.00% on 21 May 2026, closing at ₹32.57, signalling renewed investor confidence and an upgrade in its technical outlook from mildly bullish to bullish.
Read full news article
Sudarshan Pharma Industries Ltd is Rated Hold
2026-05-17 10:10:27Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleSudarshan Pharma Industries Ltd Falls 2.23%: 4 Key Factors Driving the Weekly Shift
2026-05-09 11:01:09
Key Events This Week
4 May: Technical momentum shifts to mildly bullish amid sector rally
5 May: Bullish momentum confirmed with technical upgrades and price rise to Rs.31.00
6 May: MarketsMOJO upgrades rating to Buy following strong financial performance
7 May: Technical momentum moderates to mildly bullish amid mixed signals
8 May: Week closes at Rs.30.30, down 2.23% for the week versus Sensex +1.25%

Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Indicators
2026-05-07 08:06:38Sudarshan Pharma Industries Ltd, a micro-cap player in the specialty chemicals sector, has recently experienced a nuanced shift in its technical momentum, prompting an upgrade in its Mojo Grade from Hold to Buy as of 5 May 2026. Despite a modest day decline of 2.39%, the stock’s underlying technical indicators reveal a complex but cautiously optimistic outlook for investors seeking exposure in this segment.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
26-May-2026 | Source : BSEPlease find enclosed herewith the newspaper advertisement for the Postal Ballo Notice dispatched to the shareholders of the Company on 25/May/2026 published in (i) Mumbai Lakshdeep and (ii) Financial Express.
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
25-May-2026 | Source : BSEPlease find enclosed the Notice of Postal Ballot together with Explanatory Statement benig sent to the members of the Company.
Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 By Listed Entities.
21-May-2026 | Source : BSEWe refer to the Corporate Announcement dated May 15 2026 (Annexure A) setting out fixed conversion rate of Rs.95.93 per US Dollar for FCCB issue. RBI rate as on date of signing subscription agreement revised to Rs.96.8441 per US Dollar. We enclose the revised Annexure A reflecting the updated conversion terms.
Corporate Actions
No Upcoming Board Meetings
Sudarshan Pharma Industries Ltd has declared 3% dividend, ex-date: 25 Aug 23
Sudarshan Pharma Industries Ltd has announced 1:10 stock split, ex-date: 22 Nov 24
No Bonus history available
No Rights history available









